• Proust A., et al.; HIV-1 infection and latency-reversing agents bryostatin-1 and JQ1 disrupt amyloid beta homeostasis in human astrocytes. (2020) Glia. 2020 Apr 6. doi: 10.1002/glia.23833. [pdf]


  • Wessels J.M., et al.; Medroxyprogesterone acetate alters the vaginal microbiota and microenvironment in women and increases susceptibility to HIV-1 in humanized mice. (2019) Dis Model Mech. Oct 23;12(10). pii: dmm039669. doi: 10.1242/dmm.039669. [pdf]
  • Rao S., et al.; Host mRNA decay proteins influence HIV-1 replication and viral gene expression in primary monocyte-derived macrophages. (2019) Retrovirology. Feb 7;16(1):3. doi: 10.1186/s12977-019-0465-2. [pdf]
  • Breton Y., et al.; Expression of MDM2 in Macrophages Promotes the Early Postentry Steps of HIV-1 Infection through Inhibition of p53. (2019) J. Virol. Mar 21;93(7). pii: e01871-18. doi: 10.1128/JVI.01871-18. [pdf]


  • Proust A., et al.; A new tool for detection of extracellular traps. (2018) Methods Appl Fluoresc. May 29;6(3):037002. [pdf]
  • Barat C., et al.; Astrocytes sustain long-term productive HIV-1 infection without establishment of reactivable viral latency. (2018) Glia. Feb 21; doi: 10.1002/glia.23310. [Epub ahead of print] [pdf]


  • Proust A., et al.; Contrasting effect of the latency-reversing agents bryostatin-1 and JQ1 on astrocyte-mediated neuroinflammation and brain neutrophil invasion. (2017) J. Neuroinflammation. Dec 11; 14(1):242 [pdf]
  • Nguyen, P.V. et al.; Frequency of Human CD45+ Target Cells is a Key Determinant of Intravaginal HIV-1 Infection in Humanized Mice. (2017) Sci Rep. Nov 10; 7(1):15263 [pdf]
  • Lodge R., et al.; Host MicroRNAs-221 and -222 Inhibit HIV-1 Entry in Macrophages by Targeting the CD4 Viral Receptor. (2017) Cell Rep. Oct 3; 21(1):141-153 [pdf]
  • Deshiere A. et al.; Global Mapping of the Macrophage-HIV-1 Transcriptome Reveals that Productive Infection Induces Remodeling of Host Cell DNA and Chromatin. (2017) Sci Rep. Jul 12 7(1):5238 [pdf]
  • Bolduc J.-F., et al.; Epigenetic Metabolite Acetate Inhibits Class I/II Histone Deacetylases, Promotes Histone Acetylation, and Increases HIV-1 Integration in CD4+ T Cells. (2017) J. Virol. Jul 27; 91(16):e01943-16 [pdf]
  • Dental C. et al.; HIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood-Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration. (2017) J. Immunol. Feb 1 198(3):1229-1241 [pdf]
  • Bolduc J.-F. et al.; TLR2 ligation enhances HIV-1 replication in activated CCR6+CD4+ T cells by increasing virus entry and establishing a more permissive environment to infection. (2017) J. Virol. Feb 91(4):e01402-16 [pdf]


  • Gomez A.M. et al.; HIV-1-Mediated BAFF Secretion in Macrophages Does Not Require Endosomal TLRs, Type-I IFN, and Nef, but Depends on the Cellular Phenotype Status. (2016) J. Immunol. May 1;196(9):3806-17 [pdf]


  • Sperandio S. et al.; TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability. (2015) Proc. Natl Acad. Sci. U.S.A. 112 (26) : E3392-401 [pdf]
  • Andreani G. et al.; Leishmania infantum amastigotes trigger a subpopulation of human B cells with an immunoregulatory phenotype. (2015) PLoS Negl. Trop. Dis. 9 (2) : e0003543 [pdf]
  • Gomez A.M. et al.; HIV-1-Triggered Release of Type I IFN by Plasmacytoid Dendritic Cells Induces BAFF Production in Monocytes. (2015) J. Immunol. 194 (5) : 2300-8 [pdf]
  • Ferreira V.H. et al.; Medroxyprogesterone Acetate Regulates HIV-1 Uptake and Transcytosis but Not Replication in Primary Genital Epithelial Cells, resulting in Enhanced T-Cell Infection. (2014) J. Infect. Dis. Dec 23. pii: jiu832. [Epub ahead of print][pdf]
  • Jalaguier P. et al.; Selective acquisition of host-derived ICAM-1 by HIV-1 is a matrix-dependent process (2015) Jan 1;89(1):323-36. doi: 10.1128/JVI.02701-14. Epub 2014 Oct 15.[pdf]
  • Ouellet M. et al.; Effect of galectins on viral transmission (2015) 1207:397-420. doi: 10.1007/978-1-4939-1396-1_26.


  • Pawlica P. et al.; Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses (2014) J. Virol. May; 88(10) : 5661-5676 [pdf]
  • Bertin J. et al.; Exposure of human astrocytes to leukotriene C4 promotes a CX3CL1/fractalkine-mediated transmigration of HIV-1-infected CD4(+) T cells across an in vitro blood-brain barrier model. Virology (2014) Apr; 454-455:128-38 [pdf]


  • Odaka C. et al.; Keratin 8 Is Required for the Maintenance of Architectural Structure in Thymus Epithelium. PLoS One. (2013) Sep 24;8(9):e75101.[pdf]
  • Nazli A. et al.; HIV-1 gp120 Induces TLR2- and TLR4-Mediated Innate Immune Activation in Human Female Genital Epithelium. J Immunol. 2013 Sep 16. [pdf]
  • Lambert A.A. et al.; Dendritic Cell Immunoreceptor Is a New Target for Anti-AIDS Drug Development: Identification of DCIR/HIV-1 Inhibitors. PLoS One. (2013) Jul 2;8(7): e67873. [pdf]
  • Côté S.C. et al.; Dectin-1/TLR2 and NOD2 Agonists Render Dendritic Cells Susceptible to Infection by X4-Using HIV-1 and Promote cis-Infection of CD4(+) T Cells. PLoS One. (2013) Jul 2;8(7):e67735. [pdf]
  • Kumar P. et al.; Gene expression modulation and the molecular mechanisms involved in Nelfinavir resistance in Leishmania donovani axenic amastigotes. Mol Microbiol. (2013) Jun 20. doi: 10.1111/mmi.12298. [Epub ahead of print] [pdf]
  • Gobeil L.-A. et al.; Macropinocytosis-like HIV-1 internalization in macrophages is CCR5-dependent and leads to efficient but delayed degradation in endosomal compartments. J. Virol. (2013) Jan; 87(2):735-45. [pdf]


  • Gobeil, L.-A., et al.; Differential HIV-1 endocytosis and susceptibility to virus infection in human macrophages correlate with the cell activation status. J. Virol. (2012) Oct;86(19):10399-407 [pdf]
  • Andreani G. et al.; An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells. J. Vis. Exp. (2012) Aug 15; 15(66):pii 4166.
  • Imbeault M. et al.; Exon Level Transcriptomic Profiling of HIV-1-Infected CD4(+) T Cells Reveals Virus-Induced Genes and Host Environment Favorable for Viral Replication. PLoS Pathogens. (2012) Aug; 8(8):e1002861. [pdf]
  • Garg R. and Tremblay M.J.; Miltefosine represses HIV-1 replication in human dendritic cell/T-cell cocultures partially by inducing secretion of type-I interferon. Virology. (2012) Jun 14. [pdf]
  • Andreani G. et al.; Mechanisms of interaction between protozoan parasites and HIV. Curr Opin HIV AIDS (2012) May;7(3):276-82. [pdf]
  • Sato S., et al.; Glycans, galectins, and HIV-1 infection. Ann N Y Acad Sci. (2012) Apr;1253(1):133-48. [pdf]
  • Bertin J. et al.; Leukotrienes inhibit early stages of HIV-1 infection in monocyte-derived microglia-like cells. J. Neuroinflammation (2012) Mar; 9 (1): 55. [pdf]
  • Lodge R. et al.; HIV-1 Promotes Intake of Leishmania Parasites by Enhancing Phosphatidylserine-Mediated, CD91/LRP-1-Dependent Phagocytosis in Human Macrophages. PLoS One (2012) Mar;7(3):e32761. [pdf]
  • Raymond F. et al.; Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species. Nucleic Acids Res. (2012) Feb;40(3):1131-47. [pdf]
  • Bertin J. et al.; Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system. Retrovirology (2012) Jan 11;9(1):4. [pdf]
  • St-Pierre C. et al.; Galectin-1 specific inhibitors as a new class of compounds to treat HIV-1 infection. Antimicrob Agents Chemother. (2012) Jan;56(1):154-62. [pdf]


  • Jalaguier P. et al.; Efficient production of HIV-1 virus-like particles from a mammalian expression vector requires the N-terminal capsid domain. PLoS One (2011) Nov 30. 6(11):e28314. [pdf]
  • St-Pierre C. et al.; Host Soluble Galectin-1 Promotes HIV-1 Replication Through A Direct Interaction With Glycans Of Viral Gp120 And Host CD4. J. Virol. (2011) Nov; 85(22):11742–11751. [pdf]
  • Barat C. et al.; HIV-1 replication in monocyte-derived dendritic cells is stimulated by melarsoprol, one of the main drugs against human African trypanosomiasis. J. Mol. Biol. (2011) Jul 29; 410(5):1052-64. [pdf]
  • Lambert A.A. et al.; DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway. Blood (2011) Jun 16;117(24):6589-99. [pdf]
  • Imbeault M. et al.; Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment. J Virol. (2011) Mar 85(5):2189-200 [pdf]
  • Fromentin R. et al.; Inefficient fusion due to a lack of attachment receptor/coreceptor restricts productive HIV-1 infection in human hepatoma Huh7.5 cells. J Gen Virol. (2011) Mar;92(Pt 3):587-97. [pdf]


  • Lambert A.A. et al.; HIV-1 induces DCIR expression in CD4+ T cells. PLoS Pathog. (2010) Nov 11;6(11):e1001188. [pdf]
  • Gauthier S. and Tremblay M.J.; Cholera toxin inhibits HIV-1 replication in human colorectal epithelial HT-29 cells through adenylate cyclase activation. Antiviral Res. (2010) Nov; 88(2):207-16. [pdf]
  • St-Pierre C. et al.; Galectin-1 and HIV-1 Infection. Methods Enzymol. (2010) Sep; 480 : 267-94. [pdf]
  • Tremblay M.J.; HIV-1 and pattern-recognition receptors: a marriage of convenience. Nat Immunol. (2010) May; 11(5):363-5.[pdf]
  • Nazli A. et al.; Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. (2010) Apr 8;6(4):e1000852. [pdf]
  • Kumar P. et al.; Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes. PLoS Negl Trop Dis. (2010) Mar 30;4(3):e642. [pdf]
  • Diou J. et al.; Dendritic Cells Derived from Hemozoin-Loaded Monocytes Display a Partial Maturation Phenotype that Promotes HIV-1 Trans-Infection of CD4+ T Cells and Virus Replication. J. Immunol. (2010) Mar 15;184(6):2899-907. [pdf]
  • Diou J. et al.; Malaria hemozoin modulates susceptibility of immature monocyte-derived dendritic cells to HIV-1 infection by inducing a mature-like phenotype. Cell Microbiol. (2010) Mar 15; 184 (6) : 2899-907[pdf]
  • Gauthier S. et al.; Interleukin-4 inhibits an early phase in the HIV-1 life cycle in the human colorectal cell line HT-29. Clin Immunol. (2010) Apr;135(1):146-155. [pdf]
  • Fromentin R. et al.; Human hepatoma cells transmit surface bound HIV-1 to CD4+ T cells through an ICAM-1/LFA-1-dependent mechanism. Virology (2010) Mar 15;398(2):168-175. [pdf]


  • Diou J. et al.; Ingestion of the malaria pigment hemozoin renders human macrophages less permissive to HIV-1 infection. Virology (2009) Dec 5;395(1):56-66. [pdf]
  • Majeau N. et al.; Palmitoylation of hepatitis C virus core protein is important for virion production.J. Biol. Chem. (2009) Dec 4; 284(49):33915-25. [pdf]
  • Tardif M.R. et al.; LFA-1 antagonists as agents limiting HIV-1 infection/transmission and potentiating the effect of the fusion inhibitor T-20. Antimicrob Agents Chemother. (2009) Nov 1; 53 (11) : 4656–4666 [pdf]
  • Imbeault M. et al.; Efficient magnetic bead-based separation of HIV-1-infected cells using an improved reporter virus system reveals that p53 up-regulation occurs exclusively in the virus-expressing cell population. Virology (2009) Oct 10; 393 (1) : 160-7 [pdf]
  • Garg R. et al.; Leishmania infantum Amastigotes Enhance HIV-1 Production in Cocultures of Human Dendritic Cells and CD4 T Cells by Inducing Secretion of IL-6 and TNF-alpha. PLoS Negl Trop Dis. (2009) May 26;3 (5):e441. [pdf]
  • Thibault S. et al.; TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4(+) T cells. Virology (2009) May 15;389(1-2):20-5. [pdf]
  • Thibault S. et al.; TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells. Retrovirology (2009) May 6;6(1):42. [pdf]
  • Ouellet D.L. et al.; Emergence of a complex relationship between HIV-1 and the microRNA pathway. Methods Mol Biol. (2009) 487:415-33. Review. [pdf]
  • Imbeault M. et al.; Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells. Retrovirology (2009) Jan 15. 6(1):5. [pdf]
  • Barat C. et al.; Coculture with autologous dendritic cells in the absence of foreign antigens induces an efficient replication of HIV-1 in resting CD4+ T lymphocytes. J Virol. (2009) Mar; 83 (6) : 2778-82. [pdf]
  • Maurais E. et al.; Human immunodeficiency virus type 1-anchored CD40 ligand induces secretion of the chemokine interleukin-8 by human primary macrophages. Virology. (2009) Mar 1; 385 (1) : 227–232. [pdf]


  • Gauthier S. et al.; Induction of galectin-1 expression by HTLV-I Tax and its impact on HTLV-I infectivity. Retrovirology (2008) Nov 25;5(1):105-121. [pdf]
  • Trudel N. et al.; Intracellular Survival of Leishmania Species That Cause Visceral Leishmaniasis Is Significantly Reduced by HIV-1 Protease Inhibitors. J. Infect. Dis. (2008) Nov 1;198(9):1292-9. [pdf]
  • Ubeda J. et al.; Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy. Genome Biol. (2008) Jul 18; 9 (7):R115. [pdf]
  • Lambert A.A. et al.; The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood. (2008) Aug 15; 112 (4):1299-307. [pdf]
  • Garg R. et al.; Leishmania infantum Promastigotes Reduce Entry of HIV-1 into Macrophages through a Lipophosphoglycan-Mediated Disruption of Lipid Rafts. J Infect Dis. (2008) Jun 15; 197 (12):1701-8. [pdf]
  • Barat C. et al.; Extracellular ATP reduces HIV-1 transfer from immature dendritic cells to CD4+ T lymphocytes. Retrovirology. (2008) Mar 28; 5: 30. [pdf]
  • Ouellet D.L. et al.; Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res. (2008) Apr; 36 (7):2353-65. [pdf]
  • Simard S. et al.; LPS reduces HIV-1 replication in primary human macrophages partly through an endogenous production of type I interferons. Clin Immunol. (2008) May; 127 (2):198-205. [pdf]
  • Fadili K.E. et al.; Modulation of gene expression in human macrophages treated with the anti-Leishmania pentavalent antimonial drug Pentostam. Antimicrob Agents Chemother. (2008) Feb; 52 (2):526-33. [pdf]
  • Mercier S. et al.; Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption. Virology (2008) Feb 5; 371 (1):121-129. [pdf]


  • Thibault S. et al.; TLR2 Signaling Renders Quiescent Naive and Memory CD4+ T Cells More Susceptible to Productive Infection with X4 and R5 HIV-Type 1. J. Immunol. (2007) Sep; 179 (7):4357-4366. [pdf]
  • Thibault S. et al.; Virus-associated host CD62L increases attachment of human immunodeficiency virus type 1 to endothelial cells and enhances trans infection of CD4+ T lymphocytes. J. Gen. Virol. (2007) Sep; 88 (Pt 9):2568-2673. [pdf]
  • Barat C. et al.; The Nucleoside Triphosphate Diphosphohydrolase-1/CD39 Is Incorporated into Human Immunodeficiency Type 1 Particles, Where It Remains Biologically Active. J. Mol Biol. (2007) Aug; 371 (1):269-282. [pdf]
  • Garg, R. et al.; Consequences of the natural propensity of Leishmania and HIV-1 to target dendritic cells. Trends Parasitol. (2007) Jul; 23(7):317-324. [pdf]
  • Gilbert C. et al.; HIV-1 replication in dendritic cell/T-cell co-cultures is increased upon incorporation of host LFA-1 due to a higher virus productive infection in immature dendritic cells. J. Virol. (2007) Jul; 81(14):7672-7682. [pdf]
  • Flamand L. et al.; Leukotriene b4 triggers the in vitro and in vivo release of potent antimicrobial agents. J. Immunol. (2007) Jun; 178(12):8036-45. [pdf]
  • Vidricaire G. et al.; HIV-1 Infection of Trophoblasts Is Independent of gp120/CD4 Interactions but Relies on Heparan Sulfate Proteoglycans. Infect Dis. (2007) May 15;195(10):1461-71. [pdf]
  • Vidricaire G. et al.; A Clathrin, Caveolae, and Dynamin-independent Endocytic Pathway Requiring Free Membrane Cholesterol Drives HIV-1 Internalization and Infection in Polarized Trophoblastic Cells. J. Mol. Biol. (2007) May 18;368(5):1267-83. [pdf]
  • Martin G. et al.; HIV-1-associated CD40 ligand trans-activates B lymphocytes and promotes infection of CD4+ T cells. J Virol. (2007) Jun;81(11):5872-81. [pdf]
  • Gilbert C et al.; Involvement of Src and Syk Tyrosine Kinases in HIV-1 Transfer from Dendritic Cells to CD4+ T Lymphocytes. J Immunol. (2007) Mar 1;178(5):2862-2871. [pdf]
  • Barat C et al.; HIV-1 Replication Is Stimulated by Sodium Stibogluconate, the Therapeutic Mainstay in the Treatment of Leishmaniasis. J. Infect. Dis. (2007) Jan 15; 195(2):236-245. [pdf]
  • Breton M et al.; A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection. J Gen Virol. (2007) Jan; 88(Pt 1):217-25. [pdf]


  • Provost P et al.; HIV-1 and the microRNA-guided silencing pathway: An intricate and multifaceted encounter. Virus Res. (2006) Nov;121(2):107-15. [pdf]
  • Sun J et al.; HIV-1-mediated syncytium formation promotes cell-to-cell transfer of Tax protein and HTLV-I gene expression. Virus Res. (2006) Jun; 118(1-2):120-129. [pdf]
  • Zhao C et al.; In primary human monocyte-derived macrophages exposed to Human immunodeficiency virus type 1, does the increased intracellular growth of Leishmania infantum rely on its enhanced uptake? J Gen Virol. (2006) May; 87(Pt 5):1295-302.[pdf]


  • Vidricaire G et al.; Rab5 and Rab7, but Not ARF6, Govern the Early Events of HIV-1 Infection in Polarized Human Placental Cells. J Immunol. (2005) Nov 15; 175(10):6517-6530. [pdf]
  • Tardif MR et al.; LFA-1 is a key determinant for preferential infection of memory CD4+ T cells by human immunodeficiency virus type 1. J Virol. (2005) Nov; 79(21):13714-24. [pdf]
  • Gilbert C et al.; Statins Could Be Used to Control Replication of Some Viruses, Including HIV-1. Viral Immunol. (2005); 18(3):474-89. [pdf]
  • Breton M et al.; Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis. Infect Immun. (2005) Oct; 73(10):6372-82. [pdf]
  • Giguère JF et al.; Virus Attachment and Replication Are Promoted after Acquisition of Host CD28 and CD152 by HIV-1.J Infect Dis. (2005) Oct 1; 192(7):1265-8. [pdf]
  • Tardif MR et al.; Regulation of LFA-1 Activity through Cytoskeleton Remodeling and Signaling Components Modulates the Efficiency of HIV Type-1 Entry in Activated CD4+ T Lymphocytes. J Immunol. (2005) Jul 15; 175(2):926-935. [pdf]
  • Pare ME et al.; A new sensitive and quantitative HTLV-I-mediated cell fusion assay in T cells. Virology. (2005) Aug 1;338(2):309-22. [pdf]
  • Cantin, R et al.; Plunder and stowaways : incorporation of cellular proteins by enveloped viruses. J Virol. (2005) Jun; 79(11):6577-87. [pdf]
  • Martin, G et al.; Envelope glycoproteins are dispensable for insertion of host HLA-DR molecules within nascent human immunodeficiency virus type 1 particles. Virology. (2005) May 10; 335(2):286-90. [pdf]
  • Zhao, C et al.; DC-SIGN-Mediated Transfer of HIV-1 Is Compromised by the Ability of Leishmania infantum to Exploit DC-SIGN as a Ligand. J Infect Dis. (2005) May 15; 191(10):1665-9. [pdf]
  • Roy, J et al.; HIV Type 1 Can Act as an APC upon Acquisition from the Host Cell of Peptide-Loaded HLA-DR and CD86 Molecules. J Immunol. (2005) Apr 15; 174(8):4779-4788. [pdf]
  • Ouellet, M et al.; Galectin-1 Acts as a Soluble Host Factor That Promotes HIV-1 Infectivity through Stabilization of Virus Attachment to Host Cells. J Immunol. (2005) Apr 1; 174(7):4120-6. [pdf]
  • Tardif, MR et al.; Tetraspanin CD81 Provides a Costimulatory Signal Resulting in Increased Human Immunodeficiency Virus Type 1 Gene Expression in Primary CD4+ T Lymphocytes through NF-kB, NFAT, and AP-1 Transduction Pathways. J Virol. (2005) Apr; 79(7):4316-28. [pdf]
  • Sun, J. et al.; Influenza virus activates human immunodeficiency virus type-1 gene expression in human CD4-expressing T cells through an NF-kB-dependent pathway. Clin Immunol. (2005) Feb; 114(2):190-8. [pdf]


  • Lemieux, AM. et al.; T cell activation leads to poor activation of HIV-1 clade E LTR and weak association of NF-kB and NFAT to its enhancer region. J Biol Chem. (2004) Dec; 279(51):52949-52960. [pdf]
  • Langlois, M. et al.; Activation of HTLV-I gene transcription by protein tyrosine phosphatase inhibitors. Virology (2004) Nov; 329(2):395-411. [pdf]
  • Giguere JF et al.; Statin Compounds Reduce Human Immunodeficiency Virus Type 1 Replication by Preventing the Interaction between Virion-Associated Host Intercellular Adhesion Molecule 1 and Its Natural Cell Surface Ligand LFA-1. J Virol. (2004) Nov; 78(21):12062-5. [pdf]
  • Beausejour Y et al.; Interaction between the Cytoplasmic Domain of ICAM-1 and Pr55Gag Leads to Acquisition of Host ICAM-1 by Human Immunodeficiency Virus Type 1. J Virol. (2004) Nov; 78(21):11916-25. [pdf]
  • Vidricaire G et al.; Endocytic host cell machinery plays a dominant role in intracellular trafficking of incoming human immunodeficiency virus type 1 in human placental trophoblasts. J Virol. (2004) Nov; 78(21):11904-15. [pdf]
  • Zhao C et al.; Leishmania infantum enhances human immunodeficiency virus type-1 replication in primary human macrophages through a complex cytokine network. Clin Immunol. (2004) Oct; 113(1):81-8. [pdf]
  • Fortin, JF et al.; Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kB, and AP-1 induction. J Biol Chem. (2004) Sep 13; 279(38):39520-39531. [pdf]
  • Beausejour, Y et al.; Susceptibility of HIV Type 1 to the Fusion Inhibitor T-20 Is Reduced on Insertion of Host Intercellular Adhesion Molecule 1 in the Virus Membrane. J Infect Dis. (2004) Sep 1; 190(5):894-902. [pdf]
  • Vidricaire, G et al.; Vers une compréhension du mécanisme de transmission du VIH in utero. Med. Sci. (Paris) (2004) Août-Septembre; 20 (8-9):784-7. [pdf]
  • Bounou, S et al.; The importance of virus-associated host ICAM-1 in human immunodeficiency virus type 1 dissemination depends on the cellular context. FASEB J. (2004) Aug; 18(11):1294-6. [pdf]
  • Martin, G et al.; HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo. Clin Immunol. (2004) Jun; 111(3):275-85. [pdf]
  • Beausejour, Y et al.; Envelope glycoproteins are not required for insertion of host ICAM-1 into human immunodeficiency virus type 1 and ICAM-1-bearing viruses are still infectious despite a suboptimal level of trimeric envelope proteins. Virology. (2004) Jun 20; 324(1):165-72. [pdf]
  • Barat, C et al.; Engagement of ICAM-3 Provides a Costimulatory Signal for Human Immunodeficiency Virus Type 1 Replication in both Activated and Quiescent CD4+ T Lymphocytes: Implications for Virus Pathogenesis. J Virol. (2004) Jun;78(12):6692-7.[pdf]
  • Giguere, JF et al.; Insertion of Host-Derived Costimulatory Molecules CD80 (B7.1) and CD86 (B7.2) into Human Immunodeficiency Virus Type 1 Affects the Virus Life Cycle. J Virol. (2004) Jun; 78(12):6222-32. [pdf]
  • Zhao, C et al.; Leishmania infantum Promotes Replication of HIV Type 1 in Human Lymphoid Tissue Cultured Ex Vivo by Inducing Secretion of the Proinflammatory Cytokines TNF-a and IL-1a. J Immunol. (2004) Mar; 172(5):3086-3093. [pdf]


  • Tardif, MR et al.; Presence of Host ICAM-1 in Human Immunodeficiency Virus Type 1 Virions Increases Productive Infection of CD4(+) T Lymphocytes by Favoring Cytosolic Delivery of Viral Material. J Virol 2003 Nov;77(22):12299-309. [pdf]
  • Dumais, N et al.; T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1. J Virol (2003) Oct;77(20):11170-9. [pdf]
  • Losier, M et al.; Virion-bound ICAM-1 and activated LFA-1: a combination of factors conferring resistance to neutralization by sera from human immunodeficiency virus type 1-infected individuals independently of the disease status and phase. Clin Immunol. (2003) Aug;108(2):111-8. [pdf]
  • Ouellet, M et al.; NF-k B Induction by Bisperoxovanadium Compounds Requires CD45, p36LAT, PKC and IKK Activity and Exhibits Kinetics of Activation Comparable to Those of TCR/CD28 Coengagement. Biochemistry 2003 July 15 42(27):8260-71. [pdf]
  • Ouellet, M et al.; Protein Tyrosyl Phosphatases in T Cell Activation : Implication for Human Immunodeficiency Virus Transcriptional Activation. Prog. Nucl. Acid Res. and Mol. Biol. edited by Kivie Moldave; Academic Press; (2003) July 14; Vol. 73 pp 69-105 ISBN 0-12-540073-X. [buy] [pdf]
  • Vidricaire, G et al.; The Low Viral Production in Trophoblastic Cells Is Due to a High Endocytic Internalization of the Human Immunodeficiency Virus Type 1 and Can Be Overcome by the Pro-inflammatory Cytokines Tumor Necrosis Factor-alpha and Interleukin-1.J Biol Chem. (2003) May 2 278(18):15832-41. [pdf]
  • Barat, C et al.; Treatment of human T cells with bisperoxovanadium phosphotyrosyl phosphatase inhibitors leads to activation of cyclooxygenase-2 gene. J Biol Chem. (2003) Feb 28; 278(9):6992-7000. [pdf]
  • Cantin, R et al.; Incorporation de molécules membranaires de la cellule hôte dans l’enveloppe du virus d’immunodéficience humaine. Virologie (2003) Jan-Fev; 7 (1) : 17-24. [pdf]


  • Barat, C et al.; Adhesion molecules as costimulators: ICAM-3 signaling potentiates CD3-mediated HIV-1 stimulation. Ann N Y Acad Sci. (2002) Nov; 973:590-3. [pdf]
  • Roy, J et al.; The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother. (2002) Nov; 46 (11):3447-55. [pdf]
  • Ryckman, C et al.; HIV-1 Transcription and Virus Production Are Both Accentuated by the Proinflammatory Myeloid-Related Proteins in Human CD4(+) T Lymphocytes. J Immunol. (2002) Sep 15;169(6):3307-13. [pdf]
  • Giguere, JF et al.; New Insights into the Functionality of a Virion-Anchored Host Cell Membrane Protein: CD28 Versus HIV Type 1. J Immunol. (2002) Sep 1;169(5):2762-71.[pdf]
  • Barat, C et al.; Engagement of CD43 Enhances Human Immunodeficiency Virus Type 1 Transcriptional Activity and Virus Production That Is Induced upon TCR/CD3 Stimulation. J Biol Chem. (2002) Aug 9;277(32):28714-24. [pdf]
  • Robichaud, GA et al.; Nuclear Factor of Activated T Cells Is a Driving Force for Preferential Productive HIV-1 Infection of CD45RO-expressing CD4+ T Cells.J Biol Chem. (2002) Jun 28;277(26):23733-23741. [pdf]
  • Sun J, et al.; Syncytium Formation and HIV-1 Replication Are Both Accentuated by Purified Influenza and Virus-associated Neuraminidase.J Biol Chem. (2002) Mar 22;277 (12):9825-9833. [pdf]
  • Gagne JF, et al.; Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes. Biochim Biophys Acta. (2002) Feb 1;1558(2):198-210. [pdf]
  • Bounou S, et al.; Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo.J Virol. (2002) Feb;76(3):1004-14. [pdf]
  • Dumais N, et al.; Prostaglandin E(2)-mediated activation of HIV-1 long terminal repeat transcription in human T cells necessitates CCAAT/enhancer binding protein (C/EBP) binding sites in addition to cooperative interactions between C/EBPbeta and cyclic adenosine 5′-monophosphate response element binding protein. J Immunol. (2002) Jan 1;168(1):274-82. [pdf]


  • Cantin R, et al.; A novel virus capture assay reveals a differential acquisition of host HLA-DR by clinical isolates of human immunodeficiency virus type 1 expanded in primary human cells depending on the nature of producing cells and the donor source. J Gen Virol. (2001) Dec;82(Pt 12):2979-87. [pdf]
  • Barbeau B, et al.; Negative regulation of the NFAT1 factor by CD45: implication in HIV-1 long terminal repeat activation. J Immunol. (2001) Sep 1;167(5):2700-13. [pdf]
  • Bestman-Smith, J. et al.; Sodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachment.Antimicrob Agents Chemother. (2001) Aug; 45(8):2229-37. [pdf]
  • Genois N, et al.; Inhibition of HIV-1-mediated syncytium formation and virus replication by the lipophosphoglycan from Leishmania donovani is due to an effect on early events in the virus life cycle. Clin Exp Immunol. (2001) Apr; 124(1):32-42.[pdf]
  • Sun J, et al.; Neuraminidase from a bacterial source enhances both hiv-1-mediated syncytium formation and the virus binding/entry process. Virology. 2001 May 25; 284(1):26-36. [pdf]
  • Fortin JF, et al.; Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1. Blood (2001) Apr 15; 97(8):2390-400.[pdf]
  • Roy J, et al.; Intercellular adhesion molecule-1 (ICAM-1) gene expression in human T cells is regulated by phosphotyrosyl phosphatase activity. Involvement of NF-kB, Ets, and palindromic interferon-g-responsive element-binding sites. J Biol Chem. (2001) May 4; 276(18):14553-61. [pdf]
  • Bounou S, et al.; Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kB- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription. J Biol Chem. (2001) Mar 2;276(9):6359-69.[pdf]


  • Genois N, et al.; Mono Mac 1: a new in vitro model system to study HIV-1 infection in human cells of the mononuclear phagocyte series. J Leukoc Biol. (2000) Dec; 68(6):854-64. [pdf]
  • Bestman-Smith J et al.; Targeting cell-free HIV and virally-infected cells with anti-HLA-DR immunoliposomes containing amphotericin B. AIDS. (2000) Nov 10; 14(16):2457-65. [pdf]
  • Roy G, et al.; Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol Biochem Parasitol. (2000) Oct;110(2):195-206. [pdf]
  • Bestman-Smith J, et al.; Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1. Biochim Biophys Acta. (2000) Sep 29; 1468(1-2):161-74. [pdf]
  • Savard M, et al..; EBV Suppresses Prostaglandin E2 Biosynthesis in Human Monocytes. J.Immunol. (2000) Jun 15; 164(12):6467-6473. [pdf]
  • Fortin JF, et al.; Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization. Virology. (2000) Mar 15; 268(2):493-503. [pdf]


  • Ouellet M, et al.; p56lck, ZAP-70, SLP-76, and Calcium-regulated Effectors Are Involved in NF-kB Activation by Bisperoxovanadium Phosphotyrosyl Phosphatase Inhibitors in Human T Cells. J Biol Chem. (1999) Dec 3; 274(49):35029-35036.[pdf]
  • Morin NJ, et al.; Reducing chorioretinal viral counts with intravitreal foscarnet injections in a rabbit model of Herpes simplex virus type-1 retinitis. J Ocul Pharmacol Ther. (1999) Oct; 15(5):465-77. [pdf]
  • Dufresne I, et al.; Targeting lymph nodes with liposomes bearing anti-HLA-DR Fab’ fragments. Biochim Biophys Acta. (1999) Oct 15; 1421(2):284-94.[pdf]
  • Fortin JF, et al.; Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection. Virology. (1999) Apr 25; 257(1):228-38.[pdf]
  • Gagne N, et al.; Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9. Sex Transm Dis. (1999) Mar; 26(3):177-83. [pdf]


  • Paquette JS, et al.; Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. J Virol. (1998) Nov; 72(11):9329-36. [pdf]
  • Dumais N, et al.;Prostaglandin E2 Up-regulates HIV-1 long terminal repeat-driven activity in T cells via NF-kB-dependent and -independent signaling pathways. J Biol Chem. (1998) Oct 16;273(42):27306-14. [pdf]
  • Barbeau B, et al.; Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assay. J Virol. (1998)Sep; 72(9): 7125-7136.[pdf]
  • Tremblay MJ, et al.; The acquisition of host-encoded proteins by nascent HIV-I.Immunol Today. (1998) Aug; 19(8): 346-351.[pdf]
  • Thivierge M, et al.; Prostaglandin E2 induces resistance to human virus-1 infection in monocyte-derived macrophages: downregulation CCR5 expression by cyclic adenosine monophosphate. Blood.(1998) Jul 1; 92(1):40-5.[pdf]
  • Bernier R, et al.; Mycobacterium tuberculosis mannose-capped lipoarabinomannan induce NF-kB-activation of human immunodeficiency virus type 1 long repeat in T cells. J Gen Virol. (1998) Jun; 79(Pt 6)1353-1361. [pdf]
  • Olivier M, et al.;Modulation of interferon-g-induced macrophage activation phosphotyrosine phosphatases inhibition. Effect on Leishmaniasis progression. J Biol Chem. (1998) May 29; 273(22):13944-9 [pdf]
  • Bernier R, et al.;; The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kB elements. J Immunol. (1998) Mar 15; 160(6): 2881-2888. [pdf]
  • Fortin JF, et al.; T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J Virol. (1998) Mar; 72(3): 2105-2112. [pdf]


  • Cantin R, et al.; The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells. Blood.(1997) Aug 1; 90(3): 1091-1100. [pdf]
  • Barbeau B, et al.; Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds. J Biol Chem. (1997) May 16; 272(20): 12968-12977. [pdf]
  • Fortin JF, et al.; Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J Virol. (1997) May 1; 71(5): 3588-3596. [pdf]
  • Briand G, et al.; Enhancement of HIV-1-induced syncytium formation in T cells by the tyrosyl kinase p56lck. Virology. (1997)Apr 28; 231(1): 10-19. [pdf]
  • Cantin R, et al.; The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J Virol. (1997) Mar 1; 71(3):1922-1930. [pdf]
  • Briand G, et al.; Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase. Virology. (1997) Feb 17; 228(2): 171-179. [pdf]
  • Bernier R, et al.; Drug sensitivity of human immunodeficiency virus type 1 isolates after ribavirin therapy. J Infect Dis. (1997) Jan 1; 175(1): 176-178. [pdf]


  • Berube P, et al.; Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule. J Virol. (1996) Jun 1; 70(6):4009-4016.[pdf]
  • Cantin R, et al.; The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology. (1996) Apr 15; 218(2):372-381. [pdf]
  • Bernier R, et al.; Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani. J Virol. (1995) Nov; 69(11): 7282-7285. [pdf]
  • Bernier R, et al.; Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1. J Virol. (1995)Jan 1; 69(1): 291-300. [pdf]
  • Tremblay M, et al.; Association of p56lck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J. (1994) Feb 15;13(4):774-783. [pdf]


  • Tremblay M, et al.; Resistance to infection by HIV-1 of peripheral blood mononuclear cells from HIV-1-infected patients is probably mediated by neutralizing antibodies. J Immunol. (1990) Nov 1; 145(9): 2896-2901. [pdf]
  • Tremblay M, et al.; Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera. J Infect Dis. (1990) Sep 1; 162(3): 735-737. [pdf]
  • Tremblay M, et al.; Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells. J Exp Med. (1990) May 1; 171(5): 1791-1796. [pdf]
  • Tremblay M, et al.; Infection of human thymic lymphocytes by HIV-1. J Acquir Immune Defic Syndr. (1990) Jan 1; 3(4): 356-360. [pdf]
  • Tremblay M, et al.; Susceptibility of EBV-carrying B cell lines to infection by HIV-1: variability of production of progeny virus and expression of viral antigens. Cancer Lett. (1989) Nov 30; 48(2): 95-103. [pdf]
  • Tremblay M, et al.; Active replication of human immunodeficiency virus type 1 by peripheral blood mononuclear cells following coincubation with herpes viruses. J Med Virol. (1989) Oct 1; 29(2): 109-114. [pdf]
  • Tremblay M, et al.; New CD4(+) cell line susceptible to infection by HIV-1. J Med Virol. (1989) Aug 1; 28(4): 243-249. [pdf]
  • Tremblay M, et al.; Susceptibility to AZT of HIV-1 variants grown in Epstein-Barr virus-transformed B cell lines. J Infect Dis. (1989) Jul 1; 160(1): 31-36. [pdf]
  • Wainberg MA, et al.; The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. Blood. (1988) Dec 1; 72(6): 1904-1910. [pdf]
  • Tremblay M, et al.; Heterogeneity of HIV-1 replication and antigen expression in EBV-transformed B cell lines. Leukemia. (1988) Dec 1; 2(12 Suppl): 233S-240S. [pdf]